Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Epidemiol Biomarkers Prev ; 8(1): 91-6, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9950245

RESUMO

Polycyclic aromatic hydrocarbon-DNA adducts were evaluated in oral cells from 98 healthy volunteers by an immunohistochemical method using a specific antiserum against benzo(a)pyrene-DNA adducts revealed by the immunoperoxidase reaction. Mean adduct content, determined as relative staining intensity by absorbance image analyzer, was significantly higher in the cells from tobacco smokers compared with nonsmokers (330 +/- 98, n = 33 versus 286 +/- 83, n = 64, respectively) with a P = 0.013 obtained by two-sample t test with equal variances. We found that in the smoker group, the PAH-DNA adduct content increases with the number of cigarettes. Thus, the relative staining intensity was 305 +/- 105 in the group smoking 1-10 cigarettes/day (n = 16), 347 +/- 77 in the 11-20 group (n = 14), and 386 +/- 112 in the group smoking more than 20 cigarettes/day (n = 3; P = 0.03 by nonparametric test for trend). No significant association was detected between PAH-DNA adducts in oral cells and variables such as residential area, oral infections, alcohol or vitamin intake, grilled food consumption, and professional activity. This work confirms and extends previous data suggesting that this immunohistochemical method might be used as a valuable dosimeter of genotoxic damage in a carcinogen-exposed population, although further studies are needed to verify the applicability of the test in high-risk populations other than smokers.


Assuntos
Benzo(a)pireno/análise , Carcinógenos/análise , Adutos de DNA/análise , Poluentes Ambientais/análise , Mucosa Bucal/citologia , Adolescente , Adulto , Poluentes Ocupacionais do Ar/análise , Consumo de Bebidas Alcoólicas , Corantes , Culinária , Emprego , Feminino , Humanos , Técnicas Imunoenzimáticas , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Doenças da Boca/metabolismo , Doenças da Boca/microbiologia , Mucosa Bucal/metabolismo , Hidrocarbonetos Policíclicos Aromáticos/análise , Características de Residência , Fumar/metabolismo , Fumar/patologia , Vitaminas/administração & dosagem
2.
Intensive Care Med ; 23(1): 119-21, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9037652

RESUMO

We describe a patient in whom clinical evidence of liver and lung dysfunction developed after he received the second dose of recombinant hepatitis B vaccine, despite no serologic evidence of viral hepatitis. However, liver biopsy specimens demonstrated both surface antigens and core antigens, possibly indicating silent hepatitis B virus infection. A search for an infective etiology for the patient's subsequent clinical deterioration in lung function did not yield pathogens: postmortem examination revealed evidence of immune complex-mediated organ injury in the liver, lungs, and kidneys.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/etiologia , Vacinas contra Hepatite B/efeitos adversos , Fígado/patologia , Síndrome do Desconforto Respiratório/etiologia , Complexo Antígeno-Anticorpo , Evolução Fatal , Humanos , Fígado/virologia , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...